Join us for The 20th BayHelix Annual Conference on Sat Jan 6, 2024! This highly anticipated event will take place at the Grand Hyatt at SFO. Get ready to immerse yourself in a day filled with insightful discussions and networking opportunities. As industry leaders gather, you'll have the chance to connect with professionals from various sectors, exchange ideas, and...
The mission of the Dermatology Summit is to build a community of people who are excited about innovation in dermatology. This conference uniquely brings together members of the financial community and business leaders from established and emerging companies in the dermatology space to help foster investment and partnerships in the next generation of dermatology companies...
We are pleased to announce that the 7th Annual Neuroscience Innovation Forum (#Sachs_NIF) will take place at the Marines Memorial Club, San Francisco on the 7th of January 2024, a day before the JP Morgan meeting and the Virtual Week will take place the week after, from the 16th - 18th of January. The forum, positioned at the beginning of JPM week, focuses on the latest developments...
The UC Davis Future and Health CEO summit, in partnership with Decimal Health, will take place during the JP Morgan 42nd Healthcare Summit to be held in San Francisco. The Summit is an invitation-only event taking place on January 7th 2024 at the City Club of San Francisco where we will bring together 250+ CEOs...
The Jones Day – MSQ Global Biopharma Symposium & Networking Reception will return to San Francisco, California! Co-hosted by Jones Day & MSQ Ventures, with our supporting organizations BioCentury Inc., The BayHelix Group, and BioAroundWorld. Our guest lists includes key industry leaders, professionals, and potential collaborators such as Merck, Daiichi Sankyo, Inc., Roche, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Henlius |...
During the last three years, we have seen explosive growth in out-licensing of Chinese innovations to global biopharma companies. Novo acquired the leading asset from KBP for $1.3B USD Janssen struck a $245M upfront payment licensing deal with Cellular Biomedicine Group (CBMG) for CAR -T cancer therapies Merck moved forward with a $9.3B ADC deal...
UC Davis Health CoLab brings 350 CEOs and senior leaders in San Francisco to discuss the impact of investments in digital health and AI.
Join us for the 2024 Pre-JPM CTIC 7th Healthcare Summit! This exciting in-person event will take place at the 5th Floor of InterContinental at 888 Howard Street, San Francisco, featuring Bob Langer as our keynote speaker on Sunday, January 7, 2024 ! The Summit is a must-attend gathering for healthcare professionals, entrepreneurs, and innovators. Get ready to dive into the latest trends, advancements, and challenges in...
Attendees will gain an understanding of major policy changes and federal policy debates in 2024. The focus is anticipating the impact of these policy changes on product approval, launch and revenue expectations in the U.S. for in line and pipeline biopharmaceuticals. Topics will include: Inflation Reduction Act Implementation, Anticipated Challenges in IP, Focus on M&A...
The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) is pleased to present the fifth annual CERSI Innovations in Regulatory Science Summit, a gathering of leaders in the academia, industry, and regulatory sectors to discuss the role of regulatory science in medical product development. The 2024 CERSI Innovations in Regulatory Science Summit...
Join the Sino-American Pharmaceutical Professionals Association (SAPA) for an exclusive in-person event during the 42nd JP Morgan Healthcare Conference week in San Francisco, California. This is an unparalleled opportunity: Engage with prominent investors, consultants, and legal experts to gain insights on market trends and strategic business guidance. Connect with life science industry leaders and understand...
Healthcare capitalization has a hangover. The boom of investment in 2021 and early 2022 led to some company over-valuations, which, coupled with geopolitical and environmental issues, has led to a major correction in the markets. What’s a company seeking working capital to do? Join EWIB-San Francisco for an informative panel conversation exploring alternative funding opportunities...
